Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation (Q34616704)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

author name string

Wolff SN

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

545-552

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A second unrelated bone marrow transplant: successful quantitative monitoring of mixed chimerism using a highly discriminative PCR-STR system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Immunoregulatory role of CD8alpha in the veto effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

IL-2-activated murine newborn liver NK cells enhance engraftment of hematopoietic stem cells in MHC-mismatched recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Inhibition of cytotoxic alloreactivity by human allogeneic mononuclear cells: evidence for veto function of CD2+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Transplantation tolerance induced by "mega dose" CD34+ cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Second bone marrow transplantation in eight children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

21 January 2018

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

MHC class Ia molecules alone control NK-mediated bone marrow graft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

HHV-6-related secondary graft failure following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Late graft rejection and second infusion of bone marrow in children with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor stem cell transplantation after autologous transplantation: experience of a single center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second bone marrow transplants for relapsed leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of second bone marrow transplant using a different donor for relapsed leukemia or graft failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second bone marrow transplantation for leukemic relapse without graft-vs.-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful engraftment using allogeneic peripheral blood progenitor cells in a patient with primary bone marrow graft failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo Osseo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703389

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703389

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34616704&oldid=2196868831"